Skip to content
Screener

Atara Biotherapeutics ATRA Q3 2025 earnings

Reported November 12, 2025 · Before market open

Revenue$3.5MBeat by $2.8M
EPS-$0.32Beat by $0.51
Revenue estimate$700.0K
EPS estimate-$0.83

Next report

Nov 11, 2026 (in 2 months)
Revenue estimate$800.0K
EPS estimate-$0.13

FAQ

When did Atara Biotherapeutics report Q3 2025 earnings?
Atara Biotherapeutics (ATRA) reported Q3 2025 earnings on November 12, 2025 before market open.
What were Atara Biotherapeutics's Q3 2025 revenue and EPS?
Atara Biotherapeutics reported revenue of $3.5M and eps of $-0.32 for Q3 2025.
Did Atara Biotherapeutics beat estimates in Q3 2025?
Revenue beat the consensus estimate of $700.0K by $2.8M. EPS beat the consensus estimate of $-0.83 by $0.51.
How did Atara Biotherapeutics's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 91.4% from $40.2M a year earlier and eps grew 89.1% from $-2.93.
Where can I find Atara Biotherapeutics's Q3 2025 SEC filings?
You can read the 8-K earnings release (0001193125-25-276209) and the 10-Q periodic report (0001193125-25-276219) directly on SEC EDGAR. The filing index links above go to sec.gov.